Literature DB >> 29778256

Hepatitis C Care in the Department of Veterans Affairs: Building a Foundation for Success.

Pamela S Belperio1, Maggie Chartier2, Rachel I Gonzalez3, Angela M Park4, David B Ross2, Tim R Morgan5, Lisa I Backus6.   

Abstract

The Department of Veterans Affairs (VA) has made significant progress in treating hepatitis C virus, experiencing more than a 75% reduction in veterans remaining to be treated since the availability of oral direct-acting antivirals. Hepatitis C Innovation Teams use lean process improvement and system redesign, resulting in practice models that address gaps in care. The key to success is creative improvements in veteran access to providers, including expanded use of nonphysician providers, video telehealth, and electronic technologies. Population health management tools monitor and identify trends in care, helping the VA tailor care and address barriers. Published by Elsevier Inc.

Entities:  

Keywords:  Direct-acting antiviral; Hepatitis C; Innovation; Population health; SVR; System redesign; Veterans

Mesh：

Substances：

Year:  2018        PMID： 29778256     DOI： 10.1016/j.idc.2018.02.011

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  8 in total

Review 1.  A Path to Ending Hepatitis C in Ethiopia: A Phased Public Health Approach to Achieve Micro-Elimination.

Authors:  Belaynew Wasie Taye
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

2.  Optimizing Hepatitis C Virus (HCV) Treatment in a US Colocated HCV/Opioid Agonist Therapy Program.

Authors:  Jackie Habchi; Aurielle M Thomas; Sophie Sprecht-Walsh; Elenita Arias; Jeffrey Bratberg; Linda Hurley; Susan Hart; Lynn E Taylor
Journal:  Open Forum Infect Dis       Date:  2020-10-13       Impact factor: 3.835

3.  Patterns of Hepatitis C-Related Inpatient Mortality in the United States in the Era of Direct-Acting Antivirals.

Authors:  Mohammad S Alzahrani; Mary K Maneno; Monika N Daftary; La'Marcus T Wingate; Earl B Ettienne; Charles D Howell
Journal:  J Gastroenterol Hepatol Res       Date:  2020-06-21

4.  Strategy Configurations Directly Linked to Higher Hepatitis C Virus Treatment Starts: An Applied Use of Configurational Comparative Methods.

Authors:  Vera Yakovchenko; Edward J Miech; Matthew J Chinman; Maggie Chartier; Rachel Gonzalez; JoAnn E Kirchner; Timothy R Morgan; Angela Park; Byron J Powell; Enola K Proctor; David Ross; Thomas J Waltz; Shari S Rogal
Journal:  Med Care       Date:  2020-05       Impact factor: 2.983

5.  Access to Comprehensive Services for Advanced Liver Disease in the Veterans Health Administration.

Authors:  S Hunter Dunn; Shari S Rogal; Marissa M Maier; Maggie Chartier; Timothy R Morgan; Lauren A Beste
Journal:  Dig Dis Sci       Date:  2019-08-20       Impact factor: 3.199

6.  Using the Electronic Health Record to Characterize the Hepatitis C Virus Care Cascade.

Authors:  Shannon M Christy; Richard R Reich; Julie A Rathwell; Susan T Vadaparampil; Kimberly A Isaacs-Soriano; Mark S Friedman; Richard G Roetzheim; Anna R Giuliano
Journal:  Public Health Rep       Date:  2021-04-08       Impact factor: 3.117

7.  The Hepatic Innovation Team Collaborative: A Successful Population-Based Approach to Hepatocellular Carcinoma Surveillance.

Authors:  Shari S Rogal; Vera Yakovchenko; Rachel Gonzalez; Angela Park; Lauren A Beste; Karine Rozenberg-Ben-Dror; Jasmohan S Bajaj; Dawn Scott; Heather McCurdy; Emily Comstock; Michael Sidorovic; Sandra Gibson; Carolyn Lamorte; Anna Nobbe; Maggie Chartier; David Ross; Jason A Dominitz; Timothy R Morgan
Journal:  Cancers (Basel)       Date:  2021-05-07       Impact factor: 6.639

Review 8.  Innovations in Hepatitis C Screening and Treatment.

Authors:  Arpan A Patel; Aileen Bui; Eian Prohl; Debika Bhattacharya; Su Wang; Andrea D Branch; Ponni V Perumalswami
Journal:  Hepatol Commun       Date:  2020-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.